Page
%P
-
Article
A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma
To determine the integrative value of contrast-enhanced computed tomography (CECT), transcriptomics data and clinicopathological data for predicting the survival of bladder urothelial carcinoma (BLCA) patients.